Evidence map›Paper›PMID 18295880›Full record

ArticlePlasmid2008

New pSC101-derivative cloning vectors with elevated copy numbers.

James Peterson, Gregory J Phillips

Open access · greenAbstract read
In one paragraph

Article in Plasmid, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Engineering a Circular Riboregulator inBiodesign research · 2020
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Tuning the dials of Synthetic Biology.Microbiology (Reading, England) · 2013
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

James PetersonDepartment of Veterinary Microbiology, Veterinary Medical Research Institute, Iowa State University, 1802 University Boulevard, Building #6, Ames, IA 50011, USA.
Gregory J Phillips
Iowa State University · US

Funding

Functions of 4.5S RNA in the bacterial cellR01GM069628 · NIGMS · IOWA STATE UNIVERSITY · PI PHILLIPS, GREGORY J · 2004 to 2007
$562k
NIGMS NIH HHS R01 GM069628
6 · The paper itself

Abstract

Mutations that increase the copy number of the pSC101 replicon have been used for construction of new cloning vectors. Replacement of glutamate at position 93 in RepA yields plasmids that replicate at medium (27 copies/cell) and high (approximately 240 copies/cell) copy numbers. Based on the crystal structure of RepE, a structurally similar replication initiator protein from the F factor, the pSC101 repA mutants are predicted to be defective in dimerization. The cloning vectors permit increased expression of gene products along with the advantages of pSC101-derivative plasmids, including stable maintenance and compatibility with ColE1 plasmids. The plasmids also allow blue/white screening for DNA inserts and impart resistance to ampicillin, chloramphenicol and kanamycin. The vectors were used in a genetic assay to suppress temperature-sensitive mutants of ffh, encoding the protein component of the Escherichia coli signal recognition particle, by overproduction of 4.5S RNA. While expression of 4.5S RNA from a wild type pSC101-derivative plasmid was not sufficient for suppression, use of the new vectors did suppress the temperature-sensitive phenotype.

Indexed as

Gene Expression Regulation, BacterialGenetic TechniquesMutationAmpicillinBacterial ProteinsChloramphenicolCloning, MolecularDNA-Binding ProteinsDNA HelicasesEscherichia coli ProteinsGenetic VectorsGenotypeKanamycinMutagenesis, Site-DirectedPlasmidsRepressor ProteinsAmpicillinBacterial ProteinsChloramphenicolDNA-Binding ProteinsDNA HelicasesEscherichia coli ProteinsKanamycinRepE protein, E colireplication initiator proteinRepressor ProteinsTrans-Activators

Identifiers

PMID18295880
PMCPMC2435062
OpenAlexW2058124388

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.